Clinical Trials
🇺🇸 FDA Page 16FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Access global clinical trial data, regulatory updates, and competitive intelligence for strategic pharma R&D and investment decisions.
Showing 181–192 of 380 articles
ASGCT 2024: Gene Therapy Advancements Take Center Stage
THMA Oncology Forum: Key Highlights and Emerging Trends
THMA Oncology Forum: Key Insights and Discussions
THMA Oncology Forum: Key Insights and Discussions Day 1
THMA Oncology Forum: Key Insights and Discussions Day 1
Palvella Therapeutics Begins Phase 2 Trial of QTORIN Rapamycin for Rare Angiokeratomas
Neurocrine Biosciences Begins Phase 1 Trial of NBIP-2118 for Obesity Treatment
CAPLYTA (Lumateperone) Ranks Highest Among FDA-Approved Adjunctive Depression Treatments in Network Meta-Analysis
Cellenkos Receives FDA Clearance for CK0802 Phase 2a Trial in Steroid-Refractory GVHD
Cellenkos Receives FDA Clearance for CK0802 Phase 1b/2a Trial in Steroid-Refractory GVHD
Alpha Tau's Alpha DaRT Achieves 100% Local Disease Control in Pancreatic Cancer Trials at DDW 2026
Takeda's TAK-881 Shows Positive Phase 2/3 Results for Primary Immunodeficiency Disease Treatment